Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Role of Micrornas in the Induction of Pancreatic Differentiation Publisher Pubmed



Sabouri E1, 2 ; Rajabzadeh A3 ; Enderami SE4 ; Saburi E2 ; Soleimanifar F5 ; Barati G6 ; Rahmati M6 ; Khamisipour G7 ; Enderami SE4
Authors

Source: Current Stem Cell Research and Therapy Published:2020


Abstract

Stem cell-based therapy is one of the therapeutic options with promising results in the treatment of diabetes. Stem cells from various sources are expanded and induced to generate the cells capable of secreting insulin. These insulin-producing cells [IPCs] could be used as an alternative to islets in the treatment of patients with diabetes. Soluble growth factors, small molecules, gene-encoding transcription factors, and microRNAs [miRNAs] are commonly used for the induction of stem cell differentiation. MiRNAs are small non-coding RNAs with 21-23 nucleotides that are involved in the regulation of gene expression by targeting multiple mRNA targets. Studies have shown the dynamic expression of miRNAs during pancreatic development and stem cell differentiation. MiR-7 and miR-375 are the most abundant miRNAs in pancreatic islet cells and play key roles in pancreatic development as well as islet cell functions. Some studies have tried to use these small RNAs for the induction of pancreatic differentiation. This review focuses on the miRNAs used in the induction of stem cells into IPCs and discusses their functions in pancreatic β-cells. © 2021 Bentham Science Publishers.
Other Related Docs
4. Micrornas and Diabetes Mellitus Type 1, Current Diabetes Reviews (2022)
7. Pancreatic Islet Differentiation of Human Embryonic Stem Cells by Microrna Overexpression, Journal of Tissue Engineering and Regenerative Medicine (2016)
15. Multiple Novel Functions of Circular Rnas in Diabetes Mellitus, Archives of Physiology and Biochemistry (2023)
19. Regulation of Cardiac Stem Cells by Micrornas: State-Of-The-Art, Biomedicine and Pharmacotherapy (2019)